XML 111 R82.htm IDEA: XBRL DOCUMENT v3.22.1
Assets and liabilities from subsidiaries held for sale and discontinued operations (Details 3) - BRL (R$)
R$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Assets and liabilities from subsidiaries held for sale and discontinued operations      
Net revenue from sales and services R$ 109,732,842 R$ 74,058,056 [1] R$ 83,004,729 [1]
Cost of products and services sold (104,827,966) (70,056,447) (78,208,786)
Gross profit 4,904,876 4,001,609 4,795,943
Operating income (expenses)      
Selling marketing and administrative   (2,605,139) (2,886,435)
Other operating income, net   149,490 141,729
Other operating income, net 96,166 64,034 140,029
Operating income (loss) before finance income (expenses) and share of profit (loss) of joint ventures and associates 1,787,014 1,545,960 2,051,237
Share of profit (loss) of subsidiaries, joint ventures and associates (17,634) (44,031) (12,709)
Operating income before financial income (expenses) and income and social contribution taxes 1,769,380 1,501,929 2,038,528
Financial result, net (762,732) (550,348) [2] (673,351) [2]
Profit (loss) before income and social contribution taxes 1,006,648 951,581 1,365,177
Income and social contribution taxes (188,034) (304,517) (469,976)
Net income from continuing operations 818,614 647,064 895,201
Net income from discontinued operations 65,264 280,633 (492,257)
Profit (loss) for the year 883,878 927,697 402,944
Depreciation and amortization for the year 1,196,355 1,127,637 [3] 1,123,627
Net cash provided by (used in) operating activities 1,603,441 2,264,013 2,372,384
Net cash used in investing activities 882,869 (1,649,015) (839,338)
Net cash provided by (used in) financing activities (2,802,574) 327,351 (2,680,322)
Effect of exchange rate changes on cash and cash equivalents in foreign currency   21,912 (21,805)
Increase (decrease) in cash and cash equivalents   964,261 (1,169,081)
Disclosed      
Assets and liabilities from subsidiaries held for sale and discontinued operations      
Net revenue from sales and services   81,241,102 89,297,975
Cost of products and services sold   (75,628,214) (83,187,109)
Gross profit   5,612,888 6,110,866
Operating income (expenses)      
Selling marketing and administrative   (4,098,377) (4,366,640)
Other operating income, net   297,544 (443,674)
Operating income (loss) before finance income (expenses) and share of profit (loss) of joint ventures and associates   1,812,055 1,300,552
Share of profit (loss) of subsidiaries, joint ventures and associates   (43,617) (12,145)
Operating income before financial income (expenses) and income and social contribution taxes   1,768,438 1,288,407
Financial result, net   (269,374) (506,854)
Profit (loss) before income and social contribution taxes   1,499,064 781,553
Income and social contribution taxes   (571,367) (378,609)
Net income from continuing operations   0 402,944
Net income from discontinued operations   0 0
Profit (loss) for the year   927,697 402,944
Depreciation and amortization for the year   1,556,599 [3] 1,499,955
Net cash provided by (used in) operating activities   3,138,119 2,924,852
Net cash used in investing activities   (2,136,405) (1,835,261)
Net cash provided by (used in) financing activities   (592,333) (2,922,229)
Effect of exchange rate changes on cash and cash equivalents in foreign currency   136,734 9,066
Increase (decrease) in cash and cash equivalents   546,115 (1,823,572)
Elimination of intersegment amounts [member]      
Assets and liabilities from subsidiaries held for sale and discontinued operations      
Net revenue from sales and services (214,715) (193,046) (127,397)
Cost of products and services sold 194,118 133,384 119,405
Gross profit (20,597) (59,662) (7,992)
Operating income (expenses)      
Other operating income, net
Operating income (loss) before finance income (expenses) and share of profit (loss) of joint ventures and associates
Share of profit (loss) of subsidiaries, joint ventures and associates
Operating income before financial income (expenses) and income and social contribution taxes
Depreciation and amortization for the year
Total Discontinued operations      
Assets and liabilities from subsidiaries held for sale and discontinued operations      
Net revenue from sales and services 9,065,795 7,183,046 (6,293,246)
Cost of products and services sold (6,901,181) (5,571,767) (4,978,323)
Gross profit 2,164,614 1,611,279 1,314,923
Operating income (expenses)      
Selling marketing and administrative   (1,493,238) (1,480,205)
Other operating income, net   148,054 (585,403)
Other operating income, net 25,815    
Operating income (loss) before finance income (expenses) and share of profit (loss) of joint ventures and associates 98,885 266,095 (750,685)
Share of profit (loss) of subsidiaries, joint ventures and associates   414 564
Operating income before financial income (expenses) and income and social contribution taxes 98,933 266,509 (750,121)
Financial result, net (146,970) 280,974 166,497
Profit (loss) before income and social contribution taxes (48,037) 547,483 (583,624)
Income and social contribution taxes   (266,850) 91,367
Net income from continuing operations   0 (492,257)
Net income from discontinued operations 65,264 280,633 492,257
Profit (loss) for the year   280,633 0
Depreciation and amortization for the year 463,414 [4] 428,962 [3] 376,328
Net cash provided by (used in) operating activities   874,106 552,468
Net cash used in investing activities   (487,390) (995,923)
Net cash provided by (used in) financing activities   (919,684) (241,907)
Effect of exchange rate changes on cash and cash equivalents in foreign currency   114,822 30,871
Increase (decrease) in cash and cash equivalents   (418,146) (654,491)
Total Discontinued operations | Oxiteno S. A. Industria e Comercio [member]      
Assets and liabilities from subsidiaries held for sale and discontinued operations      
Net revenue from sales and services 7,102,771 5,210,704 4,254,237
Cost of products and services sold (5,540,773) (4,188,711) (3,537,570)
Gross profit 1,561,998 1,021,993 716,667
Operating income (expenses)      
Selling marketing and administrative   (831,056) (737,606)
Other operating income, net   153,457 (5,348)
Other operating income, net 26,924    
Operating income (loss) before finance income (expenses) and share of profit (loss) of joint ventures and associates 610,701 344,394 (26,287)
Share of profit (loss) of subsidiaries, joint ventures and associates   414 528
Operating income before financial income (expenses) and income and social contribution taxes 610,749 344,808 (25,759)
Financial result, net (431,441) 1,482 14,464
Profit (loss) before income and social contribution taxes 179,308 346,290 (11,295)
Income and social contribution taxes   (118,132) 35,191
Net income from continuing operations   0 23,896
Net income from discontinued operations 249,303 0 (23,896)
Profit (loss) for the year   228,158 0
Depreciation and amortization for the year 308,564 [4] 275,063 [3] (222,004)
Net cash provided by (used in) operating activities   765,090 486,276
Net cash used in investing activities   (159,349) (882,894)
Net cash provided by (used in) financing activities   (1,236,490) (375,258)
Effect of exchange rate changes on cash and cash equivalents in foreign currency   114,822 30,871
Increase (decrease) in cash and cash equivalents   (515,927) (741,005)
Total Discontinued operations | Extrafarma [member]      
Assets and liabilities from subsidiaries held for sale and discontinued operations      
Net revenue from sales and services 1,986,932 1,988,411 2,060,569
Cost of products and services sold (1,384,316) (1,399,125) (1,462,313)
Gross profit 602,616 589,286 598,256
Operating income (expenses)      
Selling marketing and administrative   (662,182) (742,599)
Other operating income, net   (5,403) (580,055)
Other operating income, net (1,109)    
Operating income (loss) before finance income (expenses) and share of profit (loss) of joint ventures and associates (511,816) (78,299) (724,398)
Share of profit (loss) of subsidiaries, joint ventures and associates   0 0
Operating income before financial income (expenses) and income and social contribution taxes (511,816) (78,299) (724,398)
Financial result, net (45,265) (38,938) (32,451)
Profit (loss) before income and social contribution taxes (557,081) (117,237) (756,849)
Income and social contribution taxes   (40,453) 118,901
Net income from continuing operations   0 (637,948)
Net income from discontinued operations (401,665) 0 637,948
Profit (loss) for the year   (157,690) 0
Depreciation and amortization for the year 154,850 [4] 153,899 [3] (154,324)
Net cash provided by (used in) operating activities   111,396 23,282
Net cash used in investing activities   (6,484) (122,462)
Net cash provided by (used in) financing activities   11,272 125,852
Effect of exchange rate changes on cash and cash equivalents in foreign currency   0 0
Increase (decrease) in cash and cash equivalents   116,184 26,672
Total Discontinued operations | Elimination of intersegment amounts [member]      
Assets and liabilities from subsidiaries held for sale and discontinued operations      
Net revenue from sales and services (23,908) [5] (16,069) (21,560)
Cost of products and services sold 23,908 [5] 16,069 21,560
Gross profit 0 [5] 0 0
Operating income (expenses)      
Selling marketing and administrative   0 0
Other operating income, net   0 0
Other operating income, net [5] 0    
Operating income (loss) before finance income (expenses) and share of profit (loss) of joint ventures and associates 0 [5] 0 0
Share of profit (loss) of subsidiaries, joint ventures and associates   0 36
Operating income before financial income (expenses) and income and social contribution taxes 0 [5] 0 36
Financial result, net 329,736 [5] 318,430 (184,484)
Profit (loss) before income and social contribution taxes 329,736 [5] 318,430 184,520
Income and social contribution taxes   (108,265) (62,725)
Net income from continuing operations   0 121,795
Net income from discontinued operations 217,626 [5] 0 (121,795)
Profit (loss) for the year   210,165 0
Depreciation and amortization for the year R$ 0 [4],[5] 0 [3] 0
Net cash provided by (used in) operating activities   (2,380) 42,910
Net cash used in investing activities   (321,557) 9,433
Net cash provided by (used in) financing activities   305,534 7,499
Effect of exchange rate changes on cash and cash equivalents in foreign currency   0 0
Increase (decrease) in cash and cash equivalents   R$ (18,403) R$ 59,842
[1] For further information see Note 3.c.3.
[2] For further details, see Note 3.c.3.
[3] Balances included for complete breakdown of segment information.
[4] Balances included for complete breakdown of segment information.
[5] Elimination between continuing and discontinued operations related to the intercompany loan (PPE) between Ultrapar International and Oxiteno.